SEBI has fined Gagan Rastogi and Asiatexx Enterprises Limited amounting to Rs 750 crores. Rastogi was one of the promoter of Cals Refineries. SEBI investigation has found that the GDR amount the company raised was illegally credited to the accounts of Rastogi / his associate companies.
Wednesday, December 31, 2014
NIFTY : TOP GAINERS
Gainers | |||
LTP | % chng | Volume | |
BHEL CAIRN ULTRACEMCO DRREDDY DLF | 267.00 239.95 2,675.00 3,233.15 137.70 | 3.35 2.13 1.72 1.59 1.51 | 53,63,890 21,31,269 1,60,389 2,43,993 43,60,342 |
MARKET TO CLOSE IN GREEN
Despite negative global cues stock market in India are expected to close in green, with NIFTY gaining around 50 plus points. Both FIIs and DIIs were net buyers in cash market yesterday. Select bank, pharma and tech stocks are likely to help indices to close in green.
L&T BAGS ORDER WORTH RS 2521 CR IN DEC
Larsen and Toubro has bagged orders worth Rs.2,521 crore in December, 2014.
IPO NEWS : KOTA BASED RESONANCE EDUVENTURES PLANS LISTING
Kota (Rajasthan) based firm - Resonance Eduventures, with 28 pan-India study centres for IIT and medical entrance exams, is planning an initial public offering to raise around Rs 500 crore.
The IPO, unless priced very attractively, may not get good response as investors have burnt their fingers having invested in Career Point Limited. Career Point came IPO at Rs 300 plus, about 4 years ago is now trading below Rs 200.
NCML IPO GETS VERY POOR RESPONSE ON DAY 1
NCML IPO has received bids for just 13,800 shares as against the total offer of 60 lacs shares.
Tuesday, December 30, 2014
LUPIN GETS US FDA APPROVAL FOR PREZISTA TABLETS
Lupin has received US FDA approval for Generic Prezista® Tablets.
GOVT WITHDRAWS EXCISE DUTY CONCESSIONS ON AUTO SEGMENT, CONSUMER DURABLES
The government has decided to withdraw the excise duty concessions on the auto sector and consumer durables.
Excise duty on small cars, scooters, motorcycles and commercial vehicles was reduced to 8 per cent from 12 per cent previously. For SUVs, it was cut to 24 per cent from 30 per cent; for mid-sized cars, to 20 per cent from 24 per cent and to 24 per cent for large cars, from 27 per cent.
Excise duty on small cars, scooters, motorcycles and commercial vehicles was reduced to 8 per cent from 12 per cent previously. For SUVs, it was cut to 24 per cent from 30 per cent; for mid-sized cars, to 20 per cent from 24 per cent and to 24 per cent for large cars, from 27 per cent.
In the consumer durables sector the excise was reduced to 10 per cent from 12 per cent.
From Jan 2015, old rates will be levied.
NIFTY : TOP GAINERS
Symbol | LTP | % chng | Volume |
BHEL DRREDDY BANKBARODA NTPC INDUSINDBK | 259.00 3,188.50 1,084.00 142.10 794.05 | 1.77 1.52 1.46 1.43 1.32 | 21,45,067 1,15,125 5,55,305 20,55,449 6,08,817 |
SEBI CLEARS RINL IPO
SEBI has cleared the IPO of RINL. The government proposes to offload 48,89,84,620 shares through an offer for sale, of which 35 percent will be reserved for retail investors and 50 per cent for qualified institutional buyers.
KOTAK SECURITIES PICKS 10 STOCKS WHICH WILL DO WELL IN 2015
1.ICICI Bank: TP – Rs.390
ICICI Bank has continued to demonstrate its prowess in improving ALM, maintaining robust liability franchise, managing asset quality risk along with conserving capital. We believe management’s focus on stable growth with improving structural profitability is likely to continue. We value standalone business at Rs.314 (2.0x FY16E ABV) and subsidiaries at Rs.76.
2.IDFC: TP – Rs.172
IDFC is present in the niche infrastructure financing space and is well positioned to benefit from India’s large infrastructure opportunity. We believe, falling wholesale funding rates along with improvement in the outlook on capital market related business are future catalyst for the stock. We like its balance sheet quality where loan loss provision ratio stands robust at 3.6% (Q2FY15), providing enough cushion to its future earnings.
3.Maruti Suzuki: TP – 3644
We expect domestic passenger vehicle industry to do well in the next two to three years. Revival in small car demand and new launches will be the key volume growth drivers for the company. Margins, going ahead, will receive support from reduction in discounts and economies of scale. Apart from this, forex movement has also been favorable for the company and that should be positive for the margins
4.TCS: TP – 2786
Spends in Digital are also growing in line with expectations. In the past several quarters, TCS has reported industry – leading growth rates with sustained margins.
The global economic scenario has improved, especially in USA. While Europe is seeing deceleration in growth, the scenario may not deteriorate significantly, we believe.
5.L&T: TP – 1762
Pace of order intake has been good and should enable the company to meet its order intake guidance for the fiscal. L&T continues to be one of the best plays on infrastructure development in the country. In addition to this, the company would be a major player in upcoming opportunities in Defence, High Speed Rail and Shipbuilding.
6.Kansai Nerolac: TP – 2400
Improvement in automotive demand should benefit KNPL significantly. We also estimate KNPL to improve market share in the high margin decorative segment (currently at 15% in the country) which should aid the margins of the company. Weak crude prices and weakening prices of crude derivatives including key raw material Titanium Dioxide, which is down by 15% YoY, should improve the margins and return ratios of the company going forward.
7.Carborundum Universal: TP – 240
Carborundum Universal enjoys leadership position in the domestic abrasives market along with strong positioning in global electro-minerals and industrial ceramics market. It is well poised to benefit from the improved industrial outlook. Company would likely witness sharp recovery in operating margins on back of restructuring in the international business, going ahead.
8.Kajaria Ceramics: TP – 648
Kajaria ceramics is ideally positioned to capture the increased demand coming from housing development, development of smart cities and industrial corridors and the focus of government on Swatch Bharat Abhiyaan, with its capacity expansion plans. Along with this, company is also likely to benefit from GST implementation.
9.EIL : TP – 300
EIL enjoys leadership positioning in Indian hydrocarbon consultancy business. It would benefit from recovery in capex cycle by various upstream/downstream companies over the next few years. EIL has also been diversifying business into other geographies which would add to revenue stream going ahead.
10 Geometric: TP – 146
The management has undertaken several restructuring initiatives to improve growth, bring in predictability as well as sustain margins. These initiatives are expected to lead to improved revenue growth over the next few quarters. The order booking over past four quarters and the strong pipe-line make us optimistic on future growth prospects.
RBI: INDIA TO GROW AT 6% IN 2015
RBI says India is expected to grow at 6 percent in 2015. Falling inflation and political stability have helped check the macroeconomic vulnerabilities, while retail inflation is expected to stabilise.
Monday, December 29, 2014
NIFTY : TOP GAINERS
Symbol | LTP | % chng | Volume |
ASIANPAINT SSLT JINDALSTEL HINDALCO TATA MOTORS | 758.70 215.90 155.20 156.60 496.00 | 4.35 4.05 3.95 3.03 2.24 | 8,50,978 41,16,555 70,45,427 47,55,096 27,53,590 |
L&T wins orders worth Rs 894 cr
Larsen & Toubro's Hydrocarbon Engineering has won orders valued Rs. 894 Crores.
INSTITUTIONS NET BUY FOR RS 456 CR
Institutions - both FIIs and DIIs have net bought for Rs 456 cr in cash market on Friday.
LUPIN EYES OVERSEAS ACQUISITION
Pharma major Lupin is eyeing acquisitions in global markets, including the US, Latin America and Europe.
TODAY'S PICK FOR TRADING
BUY CALL
(AMOUNT IN RUPEES)
COMPANY
|
BUY
AT
|
STOP
LOSS
|
TARGET
|
AXIS
BANK
|
490
|
485
|
500
|
|
|
|
|
LUPIN
|
1394
|
1382
|
1437
|
DR
REDDY’S
|
3127
|
3109
|
3199
|
ICICI
BANK
|
349
|
345
|
358
|
|
|
|
|
SBI
|
306
|
303
|
314
|
|
|
|
|
SUN
PHARMA
|
808
|
801
|
833
|
Sunday, December 28, 2014
BSE REVISES CIRCUIT FILTER FOR 14 STOCKS
BSE has revised the circuit filter for the following stocks with effect from December 29, 2014.
Sr. No.
|
Scrip Code
|
Scrip Name
|
Circuit Filter % Revised to
|
1
|
538833
|
Anubhav Infrastructure Ltd
|
20
|
2
|
500285
|
Spicejet Ltd
|
10
|
3
|
509051
|
Indian Infotech & Software Ltd
|
10
|
4
|
513305
|
Moryo Industries Ltd
|
10
|
5
|
530955
|
Mindvision Capital Ltd
|
10
|
6
|
531693
|
Yantra Natural Resources Ltd
|
10
|
7
|
536672
|
VCU Data Management Ltd
|
10
|
8
|
534741
|
Virtual Global Education Ltd
|
5
|
9
|
531216
|
Comfort Intech Ltd
|
5
|
10
|
524520
|
KMC Speciality Hospitals (India) Ltd
|
5
|
11
|
531689
|
Mahavir Advanced Remedies Ltd
|
2
|
12
|
509053
|
Banas Finance Ltd
|
2
|
13
|
526001
|
Jauss Polymers Ltd
|
2
|
14
|
526735
|
Excel Castronics Ltd
|
2
|
Friday, December 26, 2014
RANBAXY's Q3 ON 28-01-2015
Ranbaxy Laboratories has informed the exchanges that a meeting of the Board of Directors of the Company will be held on January 28, 2015, inter alia, to consider and approve Standalone and Consolidated Unaudited Financial Results for the third quarter.
CARE EXPECTS TO RUPEE TO TRADE AROUND 65
CARE expects the domestic currency to hover around 64 / 65 a dollar in the coming days until there is intervention from the RBI and the global situation returns to normalcy.
SEBI BARS M P BASED FIRM
Coming down hard on an illegal realty investment scheme, estimated at about Rs.900 crore, SEBI has barred Sai Prakash Properties Development and its directors from raising funds from public. The company is based at Madhya Pradesh.
LUPIN GETS USFDA APPROVAL FOR EPIVIR TABLETS
Lupin has received US health regulator’s approval to market a generic version of ViiV Healthcare’s Epivir Tablets, used in treating HIV infection, in the American market.
DR REDDY'S CLARIFIES ON HEALTH CANADA
Dr Reddys Laboratories Ltd has filed a clarification statement with the exchanges stating that In keeping with current regulations of Health Canada, the Company has voluntarily placed under quarantine all APIs and the formulations based on APIs produced at our API facility in Srikakulam district of Andhra Pradesh intended for use in Canada. Its products continue to meet intended quality standards, and they believe that, its APIs and Finished drug products manufactured using these APIs pose no risk to the health and safety of the Canadian people. The Company is working with the agency for a satisfactory resolution of the matter. At this stage, it has no implication on any activity at the plant and hence, these are not expected to be material to the Company's operations or consolidated results.
FIIS RESUME NET BUYING
After several days of net selling in cash market, FIIs have net bought for Rs 40 cr in today's trading DIIs too have net bought for Rs 417 crores.
NIFTY : TOP GAINERS
Symbol | LTP | % chng | Volume |
DLF TECHM JINDALSTEL HCLTECH HDFC | 135.90 2,567.00 148.95 1,567.00 1,113.35 | 3.23 1.96 1.92 1.77 1.23 | 93,45,778 2,14,049 48,37,241 5,17,260 11,21,541 |
IPO ANALYSIS : NCML INDUSTRIES LIMITED - INVEST
FINANCIALS
(Rs in crores)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subscribe to:
Posts (Atom)